Budesonide Tablet, Extended Release
Product Images NDC 68682-309

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 68682-309). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oceanside Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label

This is a description of Budesonide extended-release tablets, which are available by prescription only. Each tablet contains 19mg of Budesonide and is meant to be taken once a day. It is important to swallow the tablet whole and not chew, break or crush it. Budesonide is used to treat conditions such as asthma and allergies. The medication should be kept out of reach of children and stored at room temperature away from light and moisture. More information about the medication can be found on the full prescribing information included with the product.*

FDA Label Image

Uceris-1.jpg (Uceris 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.